Cargando…
Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United Kingdom
BACKGROUND: Accurate description of current practice within advanced colorectal cancer (CRC) specialties were needed to inform an economic evaluation of the UGT1A1 pharmacogenetic test for irinotecan in the United Kingdom. METHODS: The study was based on a literature review and elicitation of expert...
Autores principales: | Shabaruddin, F H, Elliott, R A, Valle, J W, Newman, W G, Payne, K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920020/ https://www.ncbi.nlm.nih.gov/pubmed/20661248 http://dx.doi.org/10.1038/sj.bjc.6605766 |
Ejemplares similares
-
Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom
por: Palmer, D H, et al.
Publicado: (2013) -
Reply: Guesstimates are not good enough for determining what is happening in routine care
por: Shabaruddin, F H, et al.
Publicado: (2010) -
Side effects during chemotherapy predict tumour response in advanced colorectal cancer
por: Schuell, B, et al.
Publicado: (2005) -
Strengthening clinical cancer research in the United Kingdom
por: Stead, M, et al.
Publicado: (2011) -
Cancer screening and preventative care among long-term cancer survivors in the United Kingdom
por: Khan, N F, et al.
Publicado: (2010)